Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased...
TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials and expand its operations...
FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022.
While there may have been a...
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022
BC: What are the main opportunities...
THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era.
Top of...
FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group.
C³ specialises...
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch virtual health clinics in...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...